Page last updated: 2024-08-21

vancomycin and indican

vancomycin has been researched along with indican in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blaser, MJ; Gao, Z; Holzman, R; Jhawar, S; Liebes, L; Lowenstein, J; Matalon, A; Nazzal, L; Roberts, J; Singh, P	1

Other Studies

1 other study(ies) available for vancomycin and indican

Article	Year
Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017, Nov-01, Volume: 32, Issue:11 Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Biomarkers; Cresols; Female; Gastrointestinal Microbiome; Humans; Indican; Kidney Failure, Chronic; Male; Metagenome; Middle Aged; Molecular Typing; Pilot Projects; RNA, Ribosomal, 16S; Sulfuric Acid Esters; Vancomycin	2017

Article

Year

Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017, Nov-01, Volume: 32, Issue:11

Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Biomarkers; Cresols; Female; Gastrointestinal Microbiome; Humans; Indican; Kidney Failure, Chronic; Male; Metagenome; Middle Aged; Molecular Typing; Pilot Projects; RNA, Ribosomal, 16S; Sulfuric Acid Esters; Vancomycin

2017